Fibroblast-like changes in CAAs are accompanied by the downregulation of terminal differentiation markers and the upregulation of pro-inflammatory cytokines (IL-6 and PLOD2), ultimately leading to the emergence of adipocyte-derived fibroblasts that may incorporate tumor stromal components 131-133. The gene discussed is IL6; the disease is neoplasm.